To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT06647550
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT06647550
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06647550. Randomized; double masking; primary purpose treatment. Start 2024-12-12 (actual); primary completion 2025-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
- Acronym
- HDNO-1605
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Drug)
- HD-6277 100mg
- Intervention (Drug)
- HD-6277 50mg
- Intervention (Drug)
- HD-6277 25mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hyundai Pharm
Record details
- Record id
cardio:ct-nct06647550- Content hash
95c8c0df2828875f7ded32c24b5fe0df2fc871c4333b273cc48b483e3dc9840c